More about

Squamous Cell Carcinoma

News
January 11, 2023
2 min read
Save

Endoscopic surveillance reduces incidence of esophageal cancer in at-risk patients

Endoscopic surveillance reduces incidence of esophageal cancer in at-risk patients

Although individuals in China with low-grade intraepithelial neoplasia are at higher risk for developing esophageal squamous cell carcinoma, that risk can be reduced by more than 30% with surveillance endoscopy, according to research.

News
October 24, 2022
2 min read
Save

Nivolumab produces ‘significant clinical activity’ in cutaneous squamous cell carcinoma

Nivolumab produces ‘significant clinical activity’ in cutaneous squamous cell carcinoma

More than half of patients had an objective response to first-line nivolumab for locally advanced or metastatic cutaneous squamous cell carcinoma, phase 2 study results published in Cancer showed.

News
October 21, 2022
2 min read
Save

Immunosuppression not a risk factor for poor outcomes in cutaneous squamous cell carcinoma

Immunosuppression not a risk factor for poor outcomes in cutaneous squamous cell carcinoma

Immunosuppression is not an independent risk factor for poor outcomes in patients with cutaneous squamous cell carcinomas when adjusting for tumor stage, according to a study.

News
September 12, 2022
3 min read
Save

Neoadjuvant immunotherapy could be ‘transformative’ in cutaneous squamous cell carcinoma

Neoadjuvant immunotherapy could be ‘transformative’ in cutaneous squamous cell carcinoma

Neoadjuvant cemiplimab induced a pathologic complete response among a majority of patients with resectable cutaneous squamous cell carcinoma, according to results of a nonrandomized phase 2 study presented at ESMO Congress.

News
September 08, 2022
2 min read
Save

FDA safety alert: Cancers reported in scar tissue around breast implants

FDA safety alert: Cancers reported in scar tissue around breast implants

FDA issued a safety alert Thursday regarding reports of squamous cell carcinoma and various lymphomas in the scar tissue surrounding breast implants.

News
June 20, 2022
1 min read
Save

Novel RNA interference approach shows safety, efficacy in cutaneous SCC

A novel therapeutic approach targeting transforming growth factor-B1 and cyclooxygenase-2 demonstrated safety and efficacy in a small cohort of patients with cutaneous in situ squamous cell carcinoma, according to study findings.

News
May 11, 2022
2 min read
Save

Safety of paclitaxel-based regimens varies among patients with esophageal cancer

Safety of paclitaxel-based regimens varies among patients with esophageal cancer

Paclitaxel plus fluorouracil did not demonstrate OS superiority over paclitaxel plus cisplatin or paclitaxel plus carboplatin in definitive chemoradiation for locally advanced esophageal squamous cell carcinoma.

News
March 11, 2022
1 min read
Save

Differentiation, invasion risk factors in metastatic cutaneous squamous cell carcinoma

Poor differentiation and deep invasion are the most common risk factors for metastatic cutaneous squamous cell carcinoma following diameter and thickness, according to a study.

News
February 09, 2022
2 min read
Save

Nivolumab bests chemotherapy in esophageal squamous cell carcinoma treatment

Nivolumab bests chemotherapy in esophageal squamous cell carcinoma treatment

First-line treatment with nivolumab in patients with advanced esophageal squamous cell carcinoma resulted in longer overall survival compared with chemotherapy treatment alone, according to research.

News
January 18, 2022
1 min read
Save

Camrelizumab, apatinib safe, efficacious in advanced esophageal squamous cell carcinoma

Camrelizumab combined with apatinib may potentially be used as a second-line treatment for advanced esophageal squamous cell carcinoma, according to phase 2 results published in The Lancet Gastroenterology & Hepatology.

View more